For GO- and calicheamicin treatment, as well as etoposide, we also show a clear reduction in active caspase-3 when caspase-2 proteolytic activity was inhibited, thus suggesting that caspase-2 takes part in apoptosis execution in response to these agents in AML cells. The gene discussed is CASP2; the disease is acute myeloid leukemia.